Modification of tamoxifen response: what have we learned?

J Clin Oncol. 2008 Apr 1;26(10):1764-5; author reply 1765-6. doi: 10.1200/JCO.2007.15.5432.
No abstract available

Publication types

  • Kommentar
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Chemotherapy, Adjuvant
  • Cytochrome P-450 CYP2D6 / genetics*
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Humans
  • Pharmacogenetics
  • Receptors, Estrogen / metabolism
  • Selective Estrogen Receptor Modulators / metabolism
  • Selective Estrogen Receptor Modulators / therapeutic use*
  • Tamoxifen / metabolism
  • Tamoxifen / therapeutic use*

Substances

  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Tamoxifen
  • Cytochrome P-450 CYP2D6